Phar Vision Advisers, LLC Lemaitre Vascular Inc Transaction History
Phar Vision Advisers, LLC
- $178 Billion
- Q3 2025
A detailed history of Phar Vision Advisers, LLC transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 4,053 shares of LMAT stock, worth $358,447. This represents 0.2% of its overall portfolio holdings.
Number of Shares
4,053Holding current value
$358,447% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding LMAT
# of Institutions
316Shares Held
21.6MCall Options Held
5.6KPut Options Held
0-
Black Rock Inc. New York, NY3.48MShares$307 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.6MShares$142 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.57MShares$139 Million2.22% of portfolio
-
Copeland Capital Management, LLC940KShares$83.2 Million1.75% of portfolio
-
Geneva Capital Management LLC912KShares$80.7 Million1.39% of portfolio
About LEMAITRE VASCULAR INC
- Ticker LMAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 21,962,900
- Market Cap $1.94B
- Description
- LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...